author-photo

Géraldine Dominiak-Felden

Sanofi Pasteur

8

Papers

622

Citations

Citation Trend

Filter By

Papers (8) Sort By

Journal Conference Others

Monitoring vaccine and non-vaccine HPV type prevalence in the post-vaccination era in women living in the Basilicata region, Italy

2018 BMC Infectious Diseases
Show All
- Source
- Cite
- Save
Citations (18)
Estimation of the overall burden of cancers, precancerous lesions, and genital warts attributable to 9-valent HPV vaccine types in women and men in Europe

2017 Infectious Agents and Cancer
Show All
- Source
- Cite
- Save
Citations (49)
Impact and Effectiveness of the Quadrivalent Human Papillomavirus Vaccine: A Systematic Review of 10 Years of Real-world Experience

2016 Clinical Infectious Diseases
Show All
- Source
- Cite
- Save
Citations (265)
Quantitative benefit–risk assessment by MCDA of the quadrivalent HPV vaccine for preventing anal cancer in males

2016 Expert Review of Vaccines
Show All
- Source
- Cite
- Save
Citations (9)
Evaluating the Early Benefit of Quadrivalent HPV Vaccine on Genital Warts in Belgium: A Cohort Study

2015 PLOS ONE
Show All
- Source
- Cite
- Save
Citations (35)
Estimation of the epidemiological burden of HPV-related anogenital cancers, precancerous lesions, and genital warts in women and men in Europe: Potential additional benefit of a nine-valent second generation HPV vaccine compared to first generation HPV vaccines

2015 Papillomavirus Research
Show All
- Source
- Cite
- Save
Citations (60)
Impact of human papillomavirus-related genital diseases on quality of life and psychosocial wellbeing: results of an observational, health-related quality of life study in the UK

2013 BMC Public Health
Show All
- Source
- Cite
- Save
Citations (49)
Estimation of the epidemiological burden of human papillomavirus-related cancers and non-malignant diseases in men in Europe: a review

2012 BMC Cancer
Show All
- Source
- Cite
- Save
Citations (137)